India, Dec. 26 -- A less noticed part of India's healthcare system is starting to draw investor interest. A small-cap healthcare distributor is benefiting from rising demand for GLP-1 drugs, rapid growth in medical devices, and a supply chain that is slowly becoming more organised.

Delta Exchange banner With an expected Rs. 1,000 crore revenue through inorganic methods, improving profitability, and better cash flow visibility, this company is quietly building scale in a business that plays a critical role in delivering medicines and medical devices to patients across the country.

About The Company Entero Healthcare Solutions Limited (Entero) is among India's fastest-growing and leading healthcare product distribution platforms. Founded ...